false0000765880
0000765880
2019-11-05
2019-11-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
November 5, 2019
Date of Report (Date of earliest event reported)
Healthpeak Properties, Inc.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
|
Maryland
|
|
001-08895
|
|
33-0091377
|
(State of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
|
|
|
|
|
Identification Number)
|
1920 Main Street, Suite 1200
Irvine, CA 92614
(Address of principal executive offices) (Zip Code)
(949) 407-0700
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
Title of each Class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
PEAK
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
|
|
Item 5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
(d) Election of Directors
On November 5, 2019, the Board of Directors (the “Board”) of Healthpeak Properties, Inc., a Maryland corporation (the “Company”), appointed Sara Grootwassink Lewis to serve as a director of the Board until the Company’s next annual meeting of stockholders and until her successor is duly elected and qualified, effective November 5, 2019. The Board determined that Ms. Lewis qualifies as an independent director under the New York Stock Exchange listing standards and the applicable requirements of the Securities and Exchange Commission (the “SEC”).
In connection with her appointment to the Board, Ms. Lewis will receive a prorated grant of restricted stock units with a grant date fair market value of approximately $74,520 on November 7, 2019 (the “Grant Date”). The restricted stock units are subject to the terms of the Company’s 2014 Performance Incentive Plan, as amended, and will vest in full on the date of the 2020 annual meeting of stockholders. Additionally, Ms. Lewis is expected to enter into the Company’s standard form of Director’s Indemnification Agreement (incorporated herein by reference to Exhibit 10.21 to the Company’s Form 10-K filed with the SEC on February 12, 2008) and will participate in the compensation and benefits program for non-employee directors as described in the Company’s Definitive Proxy Statement filed with the SEC on March 14, 2019.
Other than the director compensation arrangements described above, there is no arrangement or understanding between Ms. Lewis and any other persons pursuant to which she was selected as a director of the Company. Furthermore, the Company has not been since the beginning of the last fiscal year, and is not currently proposed to be, a participant in any related party transaction with Ms. Lewis within the meaning of Item 404(a) of Regulation S-K.
|
|
|
Item 7.01.
|
Regulation FD Disclosure.
|
On November 5, 2019, the Company issued a press release announcing the appointment of Ms. Lewis to the Board. The text of the press release is furnished herewith as Exhibit 99.1 and is specifically incorporated herein by reference.
The information set forth in this Item 7.01 of this Current Report on Form 8-K, including the text of the press release attached as Exhibit 99.1 hereto, is being furnished to the SEC and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing with the SEC under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference therein.
|
|
|
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits.
|
|
|
Exhibit No.
|
Description
|
99.1
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
HEALTHPEAK PROPERTIES, INC.
|
|
|
Date: November 5, 2019
|
By:
|
/s/ Troy E. McHenry
|
|
Name:
|
Troy E. McHenry
|
|
Title:
|
Executive Vice President, Chief Legal Officer, General Counsel and Corporate Secretary
|
HealthpeakTM Appoints Sara Grootwassink Lewis to its Board of Directors
IRVINE, CA, November 5, 2019 – Healthpeak Properties, Inc. (NYSE: PEAK) today announced the appointment of Sara Grootwassink Lewis as an independent director to its Board of Directors, effective immediately. The appointment of Ms. Lewis expands the Board to eight directors, with an average director tenure of approximately five years.
Brian Cartwright, Healthpeak’s Chairman of the Board, stated, “The addition of Sara Lewis will complement the talent, strength and diversity of our Board. We look forward to her contributions, and I am delighted to welcome Sara to our Board.”
Ms. Lewis founded and serves as the Chief Executive Officer of Lewis Corporate Advisors, a board and capital markets advisory firm, where she leverages her decade of corporate boardroom experience and more than 20 years of corporate finance and capital markets experience. She has served on several public company boards, and currently is a director of both Sun Life Financial and Weyerhaeuser Company, where she is the Chair of the Audit Committee for both companies. Ms. Lewis has been part of the executive teams of public real estate investment trusts, including as Executive Vice President and Chief Financial Officer of Washington Real Estate Investment Trust. She also currently serves on the Leadership Board for the U.S. Chamber of Commerce at the Center for Capital Markets Competitiveness and on the Board of Trustees for the Brookings Institution. Ms. Lewis is a certified public accountant and a chartered financial analyst.
“We are pleased to have Sara join Healthpeak’s talented Board of Directors,” said Tom Herzog, Healthpeak’s Chief Executive Officer. “Her vast knowledge and experience in the REIT industry will further support our focused efforts to grow the company and deliver long-term shareholder value.”
ABOUT HEALTHPEAK PROPERTIES
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Senior Housing and Medical Office, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth. For more information regarding Healthpeak, visit www.healthpeak.com.
CONTACT
Barbat Rodgers
Senior Director – Investor Relations
949-407-0400